BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significanceMolecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
2
Wei Wang, Yang Wang, Mingxing Liu, Yifan Zhang, Tao Yang, Dongsheng Li, Yinpeng Huang, Qing Li, Guang Bai, Linlin Shi. Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivoJournal of Cellular and Molecular Medicine 2019; 23(1): 586 doi: 10.1111/jcmm.13964
3
Shi-Yan Yan, Yi Zhang, Chao Sun, Hai-Xia Cao, Guang-Ming Li, Yu-Qin Wang, Jian-Gao Fan. The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinomaOncology Letters 2016; 12(2): 951 doi: 10.3892/ol.2016.4694
4
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
5
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinomaCancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
6
Dirk J. van Leeuwen, Otto M. van Delden. Ethics and informed consent in patients with hepatocellular carcinoma: Changing roles for hepatologist and radiologistClinical Liver Disease 2015; 6(5): 122 doi: 10.1002/cld.513
7
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinomaMedicine 2018; 97(33): e11872 doi: 10.1097/MD.0000000000011872
8
Xuesong Yao, Dong Yan, Huiying Zeng, Dengzhong Liu, Huai Li. Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinomaJournal of Surgical Oncology 2016; 113(6): 672 doi: 10.1002/jso.24215
9
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample studyPLOS ONE 2019; 14(10): e0223678 doi: 10.1371/journal.pone.0223678
10
Ying Sun, Yu-jun Tan, Zhan-zhao Lu, Bing-bing Li, Cheng-hong Sun, Tao Li, Li-li Zhao, Zhong Liu, Gui-min Zhang, Jing-chun Yao, Jie Li. Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARαFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00268
11
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic areaWorld Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
12
Yuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, Kun-Ming Rau, I-Pei Wu, Chien-Hung Chen, Kwong-Ming Kee, Tsung-Hui Hu, Sheng-Nan Lu. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib useJournal of Gastroenterology and Hepatology 2017; 32(12): 1975 doi: 10.1111/jgh.13783
13
XIAO-XI KAN, QI LI, XI CHEN, YA-JIE WANG, YU-JIE LI, QING YANG, HONG-BIN XIAO, ZHI-XIN WANG, YING CHEN, XIAO-GANG WENG, WEI-YAN CAI, XIAO-XIN ZHU. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cellsOncology Reports 2016; 35(6): 3480 doi: 10.3892/or.2016.4742
14
Lujun Shen, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu, Jinhua Huang. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus SorafenibCancers 2018; 10(12): 516 doi: 10.3390/cancers10120516
15
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular CarcinomasAcademic Radiology 2018; 25(4): 423 doi: 10.1016/j.acra.2017.10.018
16
Gao-Xiong Ouyang, Yu-mei Zhang, Shao-Liang Zhu, Peng Wang, Yuan Ren, Jia-Hao Li, Yu-Kai Liu, Jun Chen, Bang-De Xiang, Le-Qun Li, Jian-Yong Liu, Zhi-Ming Zhang. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinomaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31351-3
17
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapyJournal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
18
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCCMicrobial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
19
Chaoyong Tu, Wei Chen, Shuqian Wang, Wei Tan, Jingqiang Guo, Chuxiao Shao, Weilin Wang. MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2Journal of Cellular and Molecular Medicine 2019; 23(11): 7190 doi: 10.1111/jcmm.14197
20
Hideaki Takeyama, Toru Beppu, Takaaki Higashi, Takayoshi Kaida, Kota Arima, Katsunobu Taki, Katsunori Imai, Hidetoshi Nitta, Hiromitsu Hayashi, Shigeki Nakagawa, Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Motohiko Tanaka, Yutaka Sasaki, Hideo Baba. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinomaSurgery Today 2018; 48(4): 431 doi: 10.1007/s00595-017-1603-x